The bill, called the Medicare Preservation and Drug Price Fairness Act (S. 1974), repeals the new Health Savings Account (HSA) provisions and the demonstration projects that would allow private plans to compete with Medicare.

It would also allow Medicare to “negotiate” with the pharmaceutical industry for lower drug prices, which is prohibited by language in the current law.